The race is on: Companies interested in running medical marijuana operations in New York have until May 29 to submit applications to the state Department of Health.
The DOH began accepting applications on April 27 from those interested in becoming registered organizations to manufacture and dispense medical marijuana under the Compassionate Care Act, with a goal of selecting operators by July.
Just five licenses are expected to be approved for registered organizations, with each permitted to operate up to four dispensing facilities statewide. State officials will limit the program to 20 dispensing facilities initially, with locations expected to geographically dispersed across New York.
Applicants will pay a non-refundable $10,000 application fee upon submission of a detailed plan on their infrastructure and operations; plus a registration fee of $200,000, which will be refunded to those who don’t make the cut. Those that do will be expected to grow, manufacture, distribute and dispense marijuana for medical use. [Read more at the New York Business Journal]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
SANTA FE, N.M. (AP) — New Mexico regulators have doubled the number of marijuana plants that licensed growers can cultivate as the state prepares for recreational sales to start this spring, officials announced Tuesday. Increasing the plant count makes sense “to ensure that everyone can maximize the benefits of a thriving cannabis industry,” said state…
Thailand plans to decriminalize marijuana, moving a step closer to clearing its use for recreation, after becoming the first country in Southeast Asia to legalize medical cannabis and its use in food and cosmetics. The nation’s Food and Drug Administration is set to propose the removal of marijuana from a list of controlled drugs to…
For a moment, newly available medical marijuana flower was a hot commodity in Louisiana, drawing thousands of new patients and huge lines to the state’s nine authorized pharmacies. Then it was gone. Pharmacies across the state reported supply disruptions less than two weeks after flower became available at the start of 2022. And patients have…
THE French hemp and CBD industry is waiting for a court decision this week which it hopes will overturn the Government’s ban on the sale of CBD flowers – following hearings on two successive Fridays. On Friday gone, in the Palais-Royal in the centre of Paris, France’s highest court the Council of State listened to…